EUVIMEDEUVIMED entdecken
Open Access

Impact of Bacillus licheniformis from yaks following antibiotic therapy in mouse model

Zhibo Zeng, Saisai Gong, Chuxian Quan, Shimeng Zhou, Muhammad Fakhar-E-Alam Kulyar, Mudassar Iqbal, Yan Li, Xiang Li, Jiakui Li

Applied Microbiology and Biotechnology · 2024-12 · 108 (1)

DOI: 10.1007/s00253-023-12866-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied Microbiology and Biotechnology, online erschienen am 16.01.2024. Verfasst von Zhibo Zeng und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, China. Hauptthemen laut MEDLINE: Bacillus licheniformis, Probiotics, Intestinal Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Chinese Agricultural Research Systems, Key Project of Tibet Autonomous Region, Development of a Yak Pasteurella Vaccine (YPV) Chimeric Fusion Protein Gene Vaccine Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gut microorganism (GM) is an integral component of the host microbiome and health system. Abuse of antibiotics disrupts the equilibrium of the microbiome, affecting environmental pathogens and host-associated bacteria alike. However, relatively little research on Bacillus licheniformis alleviates the adverse effects of antibiotics. To test the effect of B. licheniformis as a probiotic supplement against the effects of antibiotics, cefalexin was applied, and the recovery from cefalexin-induced jejunal community disorder and intestinal barrier damage was investigated by pathology, real-time PCR (RT-PCR), and high-throughput sequencing (HTS). The result showed that A group (antibiotic treatment) significantly reduced body weight and decreased the length of jejunal intestinal villi and the villi to crypt (V/C) value, which also caused structural damage to the jejunal mucosa. Meanwhile, antibiotic treatment suppressed the mRNA expression of tight junction proteins ZO-1, claudin, occludin, and Ki67 and elevated MUC2 expression more than the other Groups (P 0.05). Moreover, the antibiotic treatment increased the relative abundance of 4 bacterial phyla affiliated with 16 bacterial genera in the jejunum community, including the dominant Firmicutes, Proteobacteria, and Cyanobacteria in the jejunum. B. licheniformis supplements after antibiotic treatment reduced the relative abundance of Bacteroidetes and Proteobacteria and increased the relative abundance of Firmicutes, Epsilonbacteraeota, Lactobacillus, and Candidatus Stoquefichus. This study uses mimic real-world exposure scenarios by considering the concentration and duration of exposure relevant to environmental antibiotic contamination levels. We described the post-antibiotic treatment with B. licheniformis could restore intestinal microbiome disorders and repair the intestinal barrier. KEY POINTS: • B. licheniformis post-antibiotics restore gut balance, repair barrier, and aid health • Antibiotics harm the gut barrier, alter structure, and raise disease risk • Long-term antibiotics affect the gut and increase disease susceptibility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bacillus licheniformisProbioticsIntestinal DiseasesAnimalsMiceCattleAnti-Bacterial AgentsDietary SupplementsBacillotaCephalexin

Stichwörter der Autor:innen

AntibioticBacillus licheniformisGut microbiotaProbiotic supplementationYaks

Substanzen

Anti-Bacterial AgentsCephalexin

Autor:innen und Institutionen

  • College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, China.
  • Faculty of Veterinary and Animal Sciences, The Islamia University of Bahawalpur, Bahawalpur, 63100, Pakistan.
  • College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, China. xxianglli@mail.hzau.edu.cn.
  • College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, China. lijk210@mail.hzau.edu.cn.
  • College of Animals Husbandry and Veterinary Medicine, Tibet Agricultural and Animal Husbandry University, Linzhi, 860000, Tibet, China. lijk210@mail.hzau.edu.cn.

Förderung

  • Chinese Agricultural Research Systems
  • Key Project of Tibet Autonomous Region
  • Development of a Yak Pasteurella Vaccine (YPV) Chimeric Fusion Protein Gene Vaccine Fund

Zitieren

APA

Zeng, Z., Gong, S., Quan, C., Zhou, S., Kulyar, M. F., Iqbal, M., Li, Y., Li, X., & Li, J. (2024). Impact of Bacillus licheniformis from yaks following antibiotic therapy in mouse model. Applied Microbiology and Biotechnology, 108(1). https://doi.org/10.1007/s00253-023-12866-w

Vancouver

Zeng Z, Gong S, Quan C, Zhou S, Kulyar MF, Iqbal M, et al. Impact of Bacillus licheniformis from yaks following antibiotic therapy in mouse model. Applied Microbiology and Biotechnology. 2024;108(1). doi:10.1007/s00253-023-12866-w

BibTeX
@article{Zeng2024,
  author = {Zeng, Zhibo and Gong, Saisai and Quan, Chuxian and Zhou, Shimeng and Kulyar, Muhammad Fakhar-E-Alam and Iqbal, Mudassar and Li, Yan and Li, Xiang and Li, Jiakui},
  title = {Impact of Bacillus licheniformis from yaks following antibiotic therapy in mouse model},
  journal = {Applied Microbiology and Biotechnology},
  year = {2024},
  volume = {108},
  number = {1},
  doi = {10.1007/s00253-023-12866-w}
}
Kostenlos starten →